This document is a Profit and Loss (P&L) statement related to Retrophin, a biotechnology company. It includes various financial figures and percentages, though some data appears to be corrupted or incomplete. The source of the document is Deutsche Bank.
documents/vol00010-efta01457579-pdf.pdf
{"title":"RTRX P&L","document_date":"2016-05-27","document_type":"tabular","key_organizations":["Retrophin","Deutsche Bank"],"reference_numbers":["DB-SDNY-0117184","SDNY_GM_00263368","EFTA01457579"]}